Everist Genomics has received the U.S. Clinical Laboratory Improvement Amendment certification required for the company to launch its OncoDefender-CRC assay, a prognostic test for assessing the risk ...

Please provide your email address to receive an email when new articles are posted on . KidneyIntelX is a prognostic test that incorporates machine learning and predictive biomarkers. Clinical ...

MENLO PARK, Calif. & CAMBRIDGE, England & SEOUL, South Korea--(BUSINESS WIRE)--GRAIL, LLC, a healthcare company whose mission is to detect cancer early when it can be cured, highlighted the ...

Adjuvant chemotherapy for elderly patients with stage I non-small cell lung cancer (NSCLC) with tumors ≥ 4 cm: A SEER-Medicare analysis. This is an ASCO Meeting Abstract from the 2014 ASCO Annual ...

LONDON and SALT LAKE CITY, June 29, 2023 (GLOBE NEWSWIRE) -- Renalytix plc (LSE: RENX) (NASDAQ:RNLX) announces that the U.S. Food and Drug Administration (FDA) has granted De Novo marketing ...

SEOUL, South Korea--(BUSINESS WIRE)--On 28 March, Gencurix (KONEX:229000) announced that the results of clinical trials for the prediction of breast cancer prognosis were published in Scientific ...

SALT LAKE CITY, Dec. 09, 2024 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc (MYGN). (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced that its Prolaris prostate cancer ...

For decades, doctors have typically relied on measuring blood pressure and proteins in urine to determine whether a woman will develop preeclampsia, a serious hypertensive disorder that affects ...

On Thursday, Telo Genomics Corp (OTC:TDSGF) announced that the manuscript “Three-dimensional telomere profiling predicts risk of progression in smoldering multiple myeloma” was accepted for ...